Literature DB >> 11125173

Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.

Kenneth Webster1, Anna Taylor1, Kevin Gaston1.   

Abstract

Human papillomavirus (HPV) type 16 infects the genital tract and is generally acknowledged to be a causative agent of cervical cancer. HPV infection alone is not sufficient to induce cervical cancer and other factors such as steroid hormones are thought to play a role in the establishment and/or progression of this disease. The HPV-16 E2 protein is required for virus replication and modulates viral gene expression whereas the HPV-16 E7 protein is required for cell transformation. We and others have shown that both the E2 and E7 proteins can induce apoptotic cell death in HPV-transformed and non-HPV transformed cell lines. Here we show that the steroid hormones oestrogen and progesterone can both increase the levels of E2- and E7-induced apoptosis. The oestrogen metabolite 16 alpha-hydroxyoestrone also increases E2- and E7-induced cell death and the dietary component indole-3-carbinol, which reduces the formation of 16alpha-hydroxyoestrone from oestrogen, blocks the effects of oestrogen. Thus the metabolism of oestrogen to 16 alpha-hydroxyoestrone appears to be required for the effects of this hormone on E2- and E7-induced cell death. We also show that the oestrogen receptor antagonist 3-hydroxytamoxifen blocks the effects of oestrogen on E2- and E7-induced cell death, whereas the anti-progesterone RU486 blocks the effects of both progesterone and oestrogen. We discuss these results in terms of the origin and progression of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11125173     DOI: 10.1099/0022-1317-82-1-201

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

Review 1.  Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

Authors:  Bansari Patel; Sonia Elguero; Suruchi Thakore; Wissam Dahoud; Mohamed Bedaiwy; Sam Mesiano
Journal:  Hum Reprod Update       Date:  2014-11-18       Impact factor: 15.610

2.  Injectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa.

Authors:  Daniel Westreich; Naiomi Jamal; Jennifer S Smith; Doreen Schulze; Sophie Williams; Pam Michelow; Simon Levin; Cynthia Firnhaber
Journal:  Contraception       Date:  2014-01-07       Impact factor: 3.375

3.  Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Adaleen Powers; Teresa M Darragh; Sepideh Farhat; Ruth Shaber; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

Review 4.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

Review 5.  IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).

Authors:  Julia Durzyńska
Journal:  Oncol Rep       Date:  2014-09-19       Impact factor: 3.906

6.  Viruses and breast cancer.

Authors:  James S Lawson; Benjamin Heng
Journal:  Cancers (Basel)       Date:  2010-04-30       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.